What About Insurance? | GenomeWeb

What About Insurance?

More and more genetic tests are being developed to determine people's risk for disease, but as NPR's Michelle Andrews reports at the Shots blog, don't expect insurance companies to pay for all of the tests. Insurers, she says, typically only cover a test if there is strong evidence that there's a health benefit.

"You don't test for testing's sake," Susan Pisano, a spokesperson for the trade group America's Health Insurance Plans, tells Andrews.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

Widespread genome sequencing might not be justified just yet, USA Today reports.